Krüppel-like factor 2(KLF2),a potential target for neuroregenerationSurajit Hansda, Prateeksha Prateeksha, Hiranmoy Das2327-2328
Defined hydrogels for spinal cord organoids:challenges and potential applicationsWai Hon Chooi, Yuewen Wu, Shi-Yan Ng2329-2330
Neuronal trafficking as a key to functional recovery in immune-mediated neuropathiesFelix Kohle, Michael Schroeter2331-2332
Advancements in personalized stem cell models for aging-related neurodegenerative disordersMingxi Weng, Ralf Jauch2333-2334
New insights into astrocyte diversity from the lens of transcriptional regulation and their implications for neurodegenerative disease treatmentsIbrahim Olabayode Saliu, Guoyan Zhao2335-2336
Harnessing endothelial cells and vascularization strategies for nerve regenerationPapon Muangsanit, Poppy Smith2337-2338
Unraveling the potential of acute intermittent hypoxia as a strategy for inducing robust repair in multiple sclerosisValerie M.K.Verge, Nataliya Tokarska, Justin M.Naniong2339-2340
Next-generation regenerative therapy for ischemic stroke using peripheral blood mononuclear cellsMasato Kanazawa, Itaru Ninomiya, Yutaka Otsu, Masahiro Hatakeyama2341-2342
